Track the 삼익제약 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 삼익제약 has published 13 public disclosures. The latest transaction was reported on 6 July 2026 (Purchase). Among the most active insiders: 권영이. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
13 of 13 declarations
Samik Pharmaceutical is a company in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development and distribution of pharmaceutical products.